CGEN Stock Analysis: Buy, Sell, or Hold?
CGEN - Compugen Ltd
$2.71
0.05 (1.88%)
▲
5d:
-12.58%
30d:
+23.18%
90d:
+47.28%
HOLD
MODERATE Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 18, 2026
14d
Get Alerted When CGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CGEN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CGEN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CGEN is currently trading at $2.71, which is considered extended relative to its 30-day fair value range of $2.10 to $2.84.
Technical Outlook: Technically, CGEN is in a strong uptrend. Immediate support is located at $2.54, while resistance sits at $3.23.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.83 (+115.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGEN is in a strong uptrend. Immediate support is located at $2.54, while resistance sits at $3.23.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.83 (+115.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.10 -
$2.84
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 115.3% below Wall St target ($5.83)
- CAUTION: 5-day price weakness (-12.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.10 -
$2.84
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.54
Resistance Level
$3.24
Current Trend
Strong Uptrend
Technical data as of
May 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.13
Wall Street Target
$5.83
(+115.3%)
Revenue Growth (YoY)
4477.3%
Profit Margin
48.6%
Share & Embed Analysis
Last updated: May 03, 2026 12:27 AM ET
Data refreshes hourly during market hours. Next update: 1:27 AM
Data refreshes hourly during market hours. Next update: 1:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Eran Ophir
SELL
5000 shares
2026-04-14
Zurit Levine
SELL
3125 shares
2026-04-10
Zurit Levine
SELL
5375 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 60 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 60 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 47 HOLD |
